Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Variations in estrogen receptor α gene and risk of dementia, and brain volumes on MRI

Abstract

The role of estrogens in Alzheimer's disease (AD) is controversial. We investigated the association between well-recognized, and potentially functional, polymorphisms in the estrogen receptor (ER) α gene and the risk of AD in a prospective study of 6056 Caucasian older men and women aged 55 years and over. In a subset of 468 participants, we assessed volumes of the hippocampus and amygdala, which have a high density of ERα, with brain magnetic resonance imaging (MRI) (1.5 T MR unit). During a total of 35 405 person-years of follow-up (mean per persons 5.8 years), 312 new cases of dementia were detected, of whom 230 were diagnosed with AD. Neither the PvuII nor the XbaI polymorphism or haplotypes thereof were associated with the risk of all-cause dementia or AD. In contrast, we found that nondemented women who carried the PvuII p allele or haplotype ‘px’ had smaller amygdalar volumes on MRI in an allele–dose-dependent fashion. Total amygdalar volume was 4.50 (SE 0.10) in PP genotype, 4.45 (SE 0.06) in Pp genotype, and 4.18 ml (SE 0.08) in pp genotype (P trend=0.008). Further studies are required to investigate whether this smaller amygdalar volume has functional significance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ et al. Neuroprotection against oxidative stress by estrogens: structure–activity relationship. Mol Pharmacol 1997; 51: 535–541.

    Article  CAS  Google Scholar 

  2. Singh M, Meyer EM, Simpkins JW . The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague–Dawley rats. Endocrinology 1995; 136: 2320–2324.

    Article  CAS  Google Scholar 

  3. Woolley CS, Gould E, Frankfurt M, McEwen BS . Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990; 10: 4035–4039.

    Article  CAS  Google Scholar 

  4. Maki PM, Resnick SM . Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 2001; 14: 789–801.

    Article  CAS  Google Scholar 

  5. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997; 48: 1517–1521.

    Article  CAS  Google Scholar 

  6. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429–432.

    Article  CAS  Google Scholar 

  7. Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651–2662.

    Article  CAS  Google Scholar 

  8. Geerlings MI, Launer LJ, de Jong FH, Ruitenberg A, Stijnen T, van Swieten JC et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol 2003; 53: 607–615.

    Article  CAS  Google Scholar 

  9. Dhandapani KM, Brann DW . Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 2002; 67: 1379–1385.

    Article  CAS  Google Scholar 

  10. Österlund MK, Keller E, Hurd YL . The human forebrain has discrete estrogen receptor α messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 2000; 95: 333–342.

    Article  Google Scholar 

  11. Yaffe K, Lui LY, Grady D, Stone K, Morin P . Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry 2002; 51: 677–682.

    Article  CAS  Google Scholar 

  12. Isoe K, Ji Y, Urakami K, Adachi Y, Nakashima K . Genetic association of estrogen receptor gene polymorphisms with Alzheimer's disease. Alzheimer's Res 1997; 3: 195–197.

    Google Scholar 

  13. Ji Y, Urakami K, Wada-Isoe K, Adachi Y, Nakashima K . Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia. Dement Geriatr Cogn Disord 2000; 11: 119–122.

    Article  CAS  Google Scholar 

  14. Maruyama H, Toji H, Harrington CR, Sasaki K, Izumi Y, Ohnuma T et al. Lack of an association of estrogen receptor α gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol 2000; 57: 236–240.

    Article  CAS  Google Scholar 

  15. Mattila KM, Axelman K, Rinne JO, Blomberg M, Lehtimäki T, Laippala P et al. Interaction between estrogen receptor 1 and the ɛ4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett 2000; 282: 45–48.

    Article  CAS  Google Scholar 

  16. Lambert JC, Harris JM, Mann D, Lemmon H, Coates J, Cumming A et al. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001; 306: 193–197.

    Article  CAS  Google Scholar 

  17. Brandi ML, Becherini L, Gennari L, Racchi M, Bianchetti A, Nacmias B et al. Association of the estrogen receptor α gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun 1999; 265: 335–338.

    Article  CAS  Google Scholar 

  18. Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging 1997; 18: 131–138.

    Article  CAS  Google Scholar 

  19. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP . Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001; 57: 1669–1674.

    Article  CAS  Google Scholar 

  20. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278: 1349–1356.

    Article  CAS  Google Scholar 

  21. Struble RG, Rosario ER, Kircher ML, Ludwig SM, MacAdamis PJ, Watabe K et al. Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17beta estradiol. Exp Neurol 2003; 183: 638–644.

    Article  CAS  Google Scholar 

  22. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA . Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403–422.

    Article  CAS  Google Scholar 

  23. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995; 310: 970–973.

    Article  CAS  Google Scholar 

  24. Ott A, Breteler MMB, van Harskamp F, Stijnen T, Hofman A . Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998; 147: 574–580.

    Article  CAS  Google Scholar 

  25. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MMB . Incidence of dementia: does gender make a difference? Neurobiol Aging 2001; 22: 575–580.

    Article  CAS  Google Scholar 

  26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944.

    Article  CAS  Google Scholar 

  27. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–260.

    Article  Google Scholar 

  28. Breteler MMB . Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann NY Acad Sci 2000; 903: 457–465.

    Article  CAS  Google Scholar 

  29. den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126: 170–175.

    Article  CAS  Google Scholar 

  30. Cuenod CA, Denys A, Michot JL, Jehenson P, Forette F, Kaplan D et al. Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol 1993; 50: 941–945.

    Article  CAS  Google Scholar 

  31. van Meurs JBJ, Schuit SCE, Weel AE, van der Klift M, Bergink AP, Arp PP et al. Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet 2003; 12: 1745–1754.

    Article  CAS  Google Scholar 

  32. Weel AE, Uitterlinden AG, Westendorp IC, Burger H, Schuit SC, Hofman A et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 1999; 84: 3146–3150.

    CAS  PubMed  Google Scholar 

  33. Slooter AJC, Cruts M, Kalmijn S, Hofman A, Breteler MMB, Van Broeckhoven C et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 1998; 55: 964–968.

    Article  CAS  Google Scholar 

  34. Andersen PK, Borgan Ø, Gill RD, Keiding N . Statistical Models Based on Counting Processes. Springer-Verlag: Berlin, 1993.

    Book  Google Scholar 

  35. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I . An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 2003; 163: 1524–1528.

    Article  Google Scholar 

  36. Ott A, Slooter AJC, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998; 351: 1840–1843.

    Article  CAS  Google Scholar 

  37. Geerlings MI, Ruitenberg A, Witteman JC, van Swieten JC, Hofman A, van Duijn CM et al. Reproductive period and risk of dementia in postmenopausal women. JAMA 2001; 285: 1475–1481.

    Article  CAS  Google Scholar 

  38. Yaffe K, Sawaya G, Lieberburg I, Grady D . Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998; 279: 688–695.

    Article  CAS  Google Scholar 

  39. Lorentzon M, Lorentzon R, Nordstrom P . Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy Caucasian men: a cross-sectional and longitudinal study. J Clin Endocrinol Metab 2000; 85: 1666–1670.

    CAS  PubMed  Google Scholar 

  40. Albagha OM, McGuigan FE, Reid DM, Ralston SH . Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res 2001; 16: 128–134.

    Article  CAS  Google Scholar 

  41. Fugger HN, Foster TC, Gustafsson J, Rissman EF . Novel effects of estradiol and estrogen receptor α and β on cognitive function. Brain Res 2000; 883: 258–264.

    Article  CAS  Google Scholar 

  42. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C et al. Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci USA 2003; 100: 9614–9619.

    Article  CAS  Google Scholar 

  43. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I et al. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 2001; 98: 1952–1957.

    CAS  PubMed  Google Scholar 

  44. Hu XY, Qin S, Lu YP, Ravid R, Swaab DF, Zhou JN . Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients. Acta Neuropathol (Berl) 2003; 106: 213–220.

    Article  CAS  Google Scholar 

  45. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH et al. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA 2003; 290: 2263–2270.

    Article  CAS  Google Scholar 

  46. Shin A, Kang D, Nishio H, Lee MJ, Park SK, Kim SU et al. Estrogen receptor alpha gene polymorphisms and breast cancer risk. Breast Cancer Res Treat 2003; 80: 127–131.

    Article  CAS  Google Scholar 

  47. Schuit SCE, van Meurs JBJ, Bergink AP, van der Klift M, Fang Y, Leusink G et al. Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J Clin Endocrinol Metab 2004; 89: 303–309.

    Article  CAS  Google Scholar 

  48. Herrington DM, Howard TD, Brosnihan KB, McDonnell DP, Li X, Hawkins GA et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 2002; 105: 1879–1882.

    Article  CAS  Google Scholar 

  49. McEwen BS . Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91: 2785–2801.

    Article  CAS  Google Scholar 

  50. Österlund MK, Gustafsson JA, Keller E, Hurd YL . Estrogen receptor β (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERα mRNA. J Clin Endocrinol Metab 2000; 85: 3840–3846.

    PubMed  Google Scholar 

  51. Prichard Z, Jorm AF, Prior M, Sanson A, Smart D, Zhang Y et al. Association of polymorphisms of the estrogen receptor gene with anxiety-related traits in children and adolescents: a longitudinal study. Am J Med Genet 2002; 114: 169–176.

    Article  Google Scholar 

  52. Westberg L, Melke J, Landen M, Nilsson S, Baghaei F, Rosmond R et al. Association between a dinucleotide repeat polymorphism of the estrogen receptor alpha gene and personality traits in women. Mol Psychiatry 2003; 8: 118–122.

    Article  CAS  Google Scholar 

  53. Rauch SL, Shin LM, Wright CI . Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci 2003; 985: 389–410.

    Article  Google Scholar 

  54. Massana G, Serra-Grabulosa JM, Salgado-Pineda P, Gastó C, Junqué C, Massana J et al. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage 2003; 19: 80–90.

    Article  Google Scholar 

  55. Comings DE, Muhleman D, Johnson P, MacMurray JP . Potential role of the estrogen receptor gene (ESR1) in anxiety. Mol Psychiatry 1999; 4: 374–377.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The Rotterdam Study has been supported by the Research Institute for Diseases in the Elderly, funded by the Ministry of Education & Science and the Ministry of Health, Welfare and Sports, through the Netherlands Organization for Scientific Research (NWO grant 014-90-001). We thank Freek Hoebeek and Eric Achten for their help in measuring the hippocampus and the amygdala and Wendy Hugens for technical assistance in the DNA analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M M B Breteler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

den Heijer, T., Schuit, S., Pols, H. et al. Variations in estrogen receptor α gene and risk of dementia, and brain volumes on MRI. Mol Psychiatry 9, 1129–1135 (2004). https://doi.org/10.1038/sj.mp.4001553

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4001553

Keywords

This article is cited by

Search

Quick links